GenSight Biologics S.A.

GenSight Biologics S.A. - ROEverified

GSGTF

Price:

$0.09

Market Cap:

$13.97M

GenSight Biologics S.A. is a clinical-stage biotechnology firm dedicated to pioneering, advancing, and bringing to market treatments for serious eye and central nervous system disorders, specifically those linked to mitochondrial dysfunction and neurodegeneration. Their therapeutic pipeline is built upon cutting-edge gene therapy approaches, including mitochondrial targeting sequences and optogenetics technologies. The company's primary drug candidate, LUMEVOQ (GS010), is a recombinant AAV2-based gene therapy currently undergoing Phase III clinical evaluation for Leber hereditary optic neuropathy (LHON) stemming from a specific ND4 gene mutation. Another key candidate, GS030, is in Phase I/I...[Read more]

Industry

Biotechnology

IPO Date

2018-01-22

Stock Exchange

OTC

Ticker

GSGTF

The ROE as of June 2026 (TTM) for GenSight Biologics S.A. (GSGTF) is 42.20%

According to GenSight Biologics S.A.’s latest financial reports and current stock price. The company's current ROE is 42.20%. This represents a change of 76.08% compared to the average of 23.96% of the last 4 quarters.

GenSight Biologics S.A. (GSGTF) Historical ROE (quarterly & annually)

How has GSGTF ROE performed in the past?

The mean historical ROE of GenSight Biologics S.A. over the last ten years is -58.88%. The current 42.20% ROE has changed -171.67% with respect to the historical average. Over the past ten years (40 quarters), GSGTF's ROE was at its highest in in the June 2020 quarter at 3.11%. The ROE was at its lowest in in the June 2022 quarter at -334.50%.

Quarterly (TTM)
Annual

Average

-58.88%

Median

-42.62%

Minimum

-289.52%

Maximum

180.80%

GenSight Biologics S.A. (GSGTF) ROE by Quarter and Year

Discovering the peaks and valleys of GenSight Biologics S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 219.65%

Maximum Annual ROE = 180.80%

Minimum Annual Increase = -201.02%

Minimum Annual ROE = -289.52%

Quarterly (TTM)
Annual
YearROEChange
202548.26%-7.22%
202452.01%-39.17%
202385.50%-52.71%
2022180.80%-201.02%
2021-178.97%-38.19%
2020-289.52%10.74%
2019-261.45%86.56%
2018-140.15%219.65%
2017-43.84%5.91%
2016-41.40%-11.08%

GenSight Biologics S.A. (GSGTF) Average ROE

How has GSGTF ROE performed in the past?

The current ROE of GenSight Biologics S.A. (GSGTF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

61.92%

5-year avg

37.52%

10-year avg

-58.88%

GenSight Biologics S.A. (GSGTF) ROE vs. Peers

How is GSGTF’s ROE compared to its peers?

GenSight Biologics S.A.’s ROE is greater than Nxera Pharma Co., Ltd. (-15.58%), less than MedinCell S.A. (133.14%), greater than BioInvent International AB (publ) (-53.88%), greater than Race Oncology Limited (-47.44%), greater than Avacta Group Plc (-2929.47%), less than Basilea Pharmaceutica AG (27.95%), less than Viva Biotech Holdings (5.57%), greater than Healios K.K. (-75.40%), less than Allergy Therapeutics plc (409.00%), less than Beijing Tong Ren Tang Chinese Medicine Company Limited (9.74%),

Build a custom stock screener for GenSight Biologics S.A. (GSGTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GenSight Biologics S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GenSight Biologics S.A. (GSGTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GenSight Biologics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is GenSight Biologics S.A.'s ROE?

How is the ROE calculated for GenSight Biologics S.A. (GSGTF)?

What is the highest ROE for GenSight Biologics S.A. (GSGTF)?

What is the 3-year average ROE for GenSight Biologics S.A. (GSGTF)?

What is the 5-year average ROE for GenSight Biologics S.A. (GSGTF)?

How does the current ROE for GenSight Biologics S.A. (GSGTF) compare to its historical average?